239 related articles for article (PubMed ID: 19770494)
1. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
[TBL] [Abstract][Full Text] [Related]
2. Advanced therapy for juvenile arthritis.
Murray KJ; Lovell DJ
Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):361-78. PubMed ID: 12387805
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
4. Update on treatment of arthritis in children: new treatments, new goals.
Lovell DJ
Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis.
Borchers AT; Selmi C; Cheema G; Keen CL; Shoenfeld Y; Gershwin ME
Autoimmun Rev; 2006 Apr; 5(4):279-98. PubMed ID: 16697970
[TBL] [Abstract][Full Text] [Related]
7. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
McCann LJ; Woo P
Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
[TBL] [Abstract][Full Text] [Related]
8. [Juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
[TBL] [Abstract][Full Text] [Related]
9. Review of medications used in juvenile rheumatoid arthritis.
Guthrie B; Rouster-Stevens KA; Reynolds SL
Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
12. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
[TBL] [Abstract][Full Text] [Related]
13. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis].
Santos MJ; Fonseca JE; Canhão H; Conde M; José Vieira M; Costa L; Costa M; Salgado M; Melo Gomes JA;
Acta Reumatol Port; 2007; 32(1):43-7. PubMed ID: 17450764
[TBL] [Abstract][Full Text] [Related]
14. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
[TBL] [Abstract][Full Text] [Related]
15. Current management of juvenile idiopathic arthritis.
Wallace CA
Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):279-300. PubMed ID: 16546057
[TBL] [Abstract][Full Text] [Related]
16. [Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis].
Tambić-Bukovac L; Malcić I; Prohić A
Reumatizam; 2002; 49(1):20-4. PubMed ID: 12476749
[TBL] [Abstract][Full Text] [Related]
17. Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections.
Brown GT; Wright FV; Lang BA; Birdi N; Oen K; Stephens D; McComas J; Feldman BM
Arthritis Rheum; 2005 Dec; 53(6):897-904. PubMed ID: 16342103
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A
J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264
[TBL] [Abstract][Full Text] [Related]
19. Juvenile idiopathic arthritis.
Weiss JE; Ilowite NT
Pediatr Clin North Am; 2005 Apr; 52(2):413-42, vi. PubMed ID: 15820374
[TBL] [Abstract][Full Text] [Related]
20. Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis.
Moretti C; Viola S; Pistorio A; Magni-Manzoni S; Ruperto N; Martini A; Ravelli A
Ann Rheum Dis; 2005 Feb; 64(2):257-61. PubMed ID: 15647433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
